| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $53.7M | — | +24.1% |
| R&D Expense | $14.5M | — | -12.5% |
| SG&A Expense | $19.9M | — | -1.7% |
| Operating Income | -$354K | — | +94.0% |
| Pre-tax Income | -$1.6M | — | +79.6% |
| Income Tax | $91K | — | +23.0% |
| Net Income | -$1.6M | — | +78.7% |
| EPS (Basic) | -$0.01 | — | +75.0% |
| EPS (Diluted) | -$0.01 | — | +75.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $27.9M | +39.5% | +43.0% |
| Accounts Receivable | $29.3M | -3.5% | +11.3% |
| Inventory | $61.1M | +9.0% | +26.9% |
| Current Assets | $175.3M | +0.5% | +8.6% |
| Total Assets | $222.9M | +0.5% | +7.8% |
| Current Liabilities | $107.4M | +6.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.0M | — | -261.3% |
| Capital Expenditures | $233K | — | +108.0% |
| Investing Cash Flow | $9.9M | — | +929.3% |
| Financing Cash Flow | $1.2M | — | +11.3% |
| Free Cash Flow | -$3.3M | — | -243.3% |
| +54.1% |
| Total Liabilities | $154.6M | -1.4% | +2.7% |
| Stockholders' Equity | $67.6M | +5.2% | +21.7% |